Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Plott Ronald Todd bought 18,300 Phio Pharmaceuticals Corp. shares (Form 4)
Traded Nov 9, 2026 · Filed Nov 10, 2026
On Nov 9, 2026, Plott Ronald Todd (Director) bought 18,300 Phio Pharmaceuticals Corp. shares at US$0.83 for US$15,189, leaving 60,300 shares. Filed Nov 10, 2026 (Form 4).
- Bought
- 18,300 shares
- Price
- US$0.83
- Value
- US$15,189
- Holding after
- 60,300 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock, $.0001 par value | Buy | 18,300 | US$0.83 | 60,300 | Direct |
Source
Download original · View original at SEC
Related
- Phio Pharmaceuticals Corp.
- Plott Ronald Todd
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Plott Ronald Todd · Sep 30, 2026
- Form 4 · Plott Ronald Todd · Sep 29, 2026
- Form 4 · Plott Ronald Todd · Aug 20, 2026
- Form 4 · Deming David H · Nov 16, 2026
- Schedule 13G/A · CVI Investments, Inc. · Nov 16, 2026
- Form 4 · Deming David H · Nov 12, 2026
- Form 4 · Bitterman Robert J · Nov 10, 2026
- Form 4 · Bitterman Robert J · Sep 29, 2026